Skip to main content

Tumori in età pediatrica

  • Chapter
Tumori della testa e del collo
  • 887 Accesses

Riassunto

I tumori della testa e del collo rappresentano circa il 5–10% delle neoplasie pediatriche; gli organi più frequentemente colpiti sono, in ordine di frequenza, la tiroide, l’orbita, il rinofaringe, le tonsille e i seni paranasali [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliografia

  1. Chadha NK, Forte V (20i9) Pediatric head and neck malignancies. Curr Opin Otolaryngol Head Neck Surg 17:471–476

    Article  Google Scholar 

  2. Gosepath J, Spix C, Talebloo B et al (2007) Incidence of childhood cancer of the head and neck in Germany. Ann Oncol 18:1716–1721

    Article  PubMed  CAS  Google Scholar 

  3. Wexler LH, Crist WM, Helman LJ et al (2002) Rhabdomyosarcoma and the undifferentiated sarcomas. In: Pizzo PA, Poplack DG (eds) Principles and Practice of Pediatric Oncology, 4th edn. Lippincott Williams & Wilkins, Philadelphia pp 939–971

    Google Scholar 

  4. Meazza C, Ferrari A, Casanova M et al (2006) Rhabdomyosarcoma of the head and neck region: experience at the pediatric unit of the Istituto Nazionale Tumori, Milan. J Otolaryngol 35:53–59

    Article  PubMed  Google Scholar 

  5. Stevens M (2002) Rhabdomyosarcoma. In: Pinkerton R, Philip T, Fervers B (eds) Evidence-based Paediatric Oncology, BMJ Books, London, pp 3–27

    Google Scholar 

  6. Parham DM (2001) Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Mod Pathol 14:506–514

    Article  PubMed  CAS  Google Scholar 

  7. Meazza C, Ferrari A, Casanova M et al (2005) Evolving treatment strategies for parameningeal rhabdomyosarcoma: the experience of the Istituto Nazionale Tumori of Milan. Head Neck 27:49–57

    Article  PubMed  Google Scholar 

  8. Oberlin O, Rey A, Lyden E et al (2008) Prognostic factor in metastatic rhabomyosarcoma: results of a pooled analysis from United States and European cooperative groups. J Clin Oncol 26:2384–2389

    Article  PubMed  Google Scholar 

  9. Ferrari A, Casanova M (2005) Current chemo therapeutic strategies for rhabdomyosarcoma. Expert Rev Anticancer Ther 5:283–294

    Article  PubMed  CAS  Google Scholar 

  10. Crist WM, Anderson JR, Meza JL et al (2001) Intergroup Rhabdomyosarcoma Study-IV: results for patients with nonmetastatic disease. J Clin Oncol 19:3091–3102

    PubMed  CAS  Google Scholar 

  11. Koscielniak E, Harms D, Henze G et al (1999) Results of treatment for soft tissue sarcoma in childhood and adolscence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol 17:3706–3719

    PubMed  CAS  Google Scholar 

  12. Stevens MC, Rey A, Bouvet N et al (2005) Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology—SIOP Malignant Mesenchymal Tumor 89. J Clin Oncol 23:2618–2628

    Article  PubMed  Google Scholar 

  13. Raney RB, Meza J, Anderson JR et al (2002) Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through-IV, 1978-1997. Med Pediatr Oncol 38:22–32

    Article  PubMed  Google Scholar 

  14. Schuck A, Mattke AC, Schmidt B et al (2004) Group II rhabdomyosarcoma and rhabdomyosarcomalike tumors: is radiotherapy necessary? J Clin Oncol 22:143–149

    Article  PubMed  Google Scholar 

  15. Michalski JM, Meza J, Breneman JC et al (2004) Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV. Int J Radiat Oncol Biol Phys 59:1027–1038

    Article  PubMed  Google Scholar 

  16. Wolden SL, Anderson JR, Crist WM et al (1999) Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Studies I to III. J Clin Oncol 17:3468–2475

    PubMed  CAS  Google Scholar 

  17. Viswanathan AN, Grier HE, Litman HJ et al (2004) Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapy. Int J Radiat Oncol Biol Phys 58:1208–1214

    Article  PubMed  Google Scholar 

  18. Stevens MC (2005) Treatment for childhood rhabdomyosarcoma: the cost of cure. Lancet Oncol 6:77–84

    Article  PubMed  Google Scholar 

  19. Oberlin O, Rey A, Anderson J et al (2001) Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment — results of an international workshop. J Clin Oncol 19:197–204

    PubMed  CAS  Google Scholar 

  20. Bisogno G, Ferrari A, Bergeron C et al (2005) The IVADo regimen, a pilot study with ifosfamide, vincristine, actinomycin aid doxorubicin in children with metastatic soft tissue sarcoma. A pilot study by the European pediatric Soft Tissue Sarcoma Study Group. Cancer 103:1719–1724

    CAS  Google Scholar 

  21. Pappo AS, Lyden E, Breneman J et al (2001) Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: an Intergroup Rhabdomyosarcoma Study. J Clin Oncol 19:213–219

    PubMed  CAS  Google Scholar 

  22. Walterhouse DO, Lyden ER, Breitfeld PP et al (2004) Efficacy of topotecan and cyclophosphamide given as a phase II window in children with newly diagnosed metastatic rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. J Clin Oncol 22:1–7

    Article  Google Scholar 

  23. Klingebiel T, Boos J, Beske F et al (2008) Treatment of children with metstatic soft tissue sacoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial. Pediatr Blood Cancer 50:739–745

    Article  PubMed  Google Scholar 

  24. Casanova M, Ferrari A, Bisogno G et al (2004) Vinorelbine and low-dose cyclophodphamide in the treatment of pediatric sarcomas. Pilot study for the upcoming European Rhabdomyosarcoma Protocol. Cancer 101:1664–1671

    CAS  Google Scholar 

  25. Paulino AC, Simon JH, Zhen W, Wen BC (2000) Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma. Int J Radiat Oncol Phys 48:1489–1495

    Article  CAS  Google Scholar 

  26. Massimino M, Collini P, Fagundes Leite S et al (2006) Conservative surgical approach for thyroid and lymph-node involvement in papillary thyroid carcinoma of childhood and adolescence. Pediatr Blood Cancer 46:307–13

    Article  PubMed  Google Scholar 

  27. Collini P, Mattavelli F, Pellegrinelli A et al (2006) Papillary carcinoma of the thyroid gland of childhood and adolescence: morphologic subtypes, biologic behavior and prognosis: a clinicopathologic study of 42 sporadic cases treated at a single institution during a 30-year period. Am J Surg Pathol 30:1420–1426

    Article  PubMed  Google Scholar 

  28. Kumagai A, Namba H, Saenko VA et al (2004) Low frequency of BRAF1796A mutations in childhood thyroid carcinomas. J Clin Endocrinol Metab 89:4280–4284

    Article  PubMed  CAS  Google Scholar 

  29. Sandlund JT, Downing JR, Crist WM (1996) Non-Hodgkin’s lymphoma in childhood. N Engl J Med 334:1238–1248

    Article  PubMed  CAS  Google Scholar 

  30. Pfeiffer J, Kayser G, Riddder GJ (2009) Sonography-assisted cutting needle biopsy in the head and neck for the diagnosis of lymphoma: can it replace lymph node extirpation? Laryngoscope 119:689–695

    Article  PubMed  Google Scholar 

  31. Gross TG, Termuhlen AM (2007) Pediatric non-Hodgkin’s lymphoma. Curr Oncol Rep 9:459–465

    Article  PubMed  CAS  Google Scholar 

  32. Olson MR, Donaldson SS (2008) Treatment of pediatric Hodgkin lymphoma. Curr Treat Options Oncol 9:81–94

    Article  PubMed  Google Scholar 

  33. Casanova M, Ferrari A, Gandola L et al (2001) Undifferentiated nasopharyngeal carcinoma in children and adolescents: Comparison between staging systems. Ann of Oncol 12:1157–1162

    Article  CAS  Google Scholar 

  34. Rodriguez-Galindo C, Wofford M, Castelberry RP et al (2005) Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, andleucovorin for pediatric nasopharyngeal carcinoma. Cancer 103:850–857

    Article  PubMed  CAS  Google Scholar 

  35. Sultan I, Casanova, M, Ferrari A et al (2010) Differential features of nasopharyngeal carcinoma in children and adults: A SEER study. Pediatr Blood Cancer 55:279–284

    Article  PubMed  Google Scholar 

  36. Downing NL, Wolden S, Wong P et al (2009) Comparison of treatment results between adult and juvenile nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 75:1064–1070

    Article  PubMed  Google Scholar 

  37. Mertens R, Granzen B, Lassay S et al (2005) Treatment of nasopharyngeal carcinoma carcinoma in children and adolescents: definitive results of amulticenter study (NPC-91-GPOH). Cancer 104:1083–1089

    Article  PubMed  Google Scholar 

  38. Guzzo M, Ferrari A, Marcon I et al (2006) Salivary gland neoplasms in pediatric age: the experience of the Istituto Nazionale Tumori of Milan. Pediatr Blood Cancer 47:806–810

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Italia

About this chapter

Cite this chapter

Casanova, M. (2011). Tumori in età pediatrica. In: Tumori della testa e del collo. Springer, Milano. https://doi.org/10.1007/978-88-470-1806-8_20

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-1806-8_20

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-1805-1

  • Online ISBN: 978-88-470-1806-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics